Furthermore, glucose either suppressed or tended to suppress antioxidant enzyme activities in LETO and OLETF, but chronic blockade of AT1 consistently prevented this glucose effect highlighting the detriments of inappropriately activated AT1 on redox balance during the manifestation of insulin resistance, and ultimately, metabolic syndrome. The gene discussed is AGTR1; the disease is metabolic syndrome.